3 recruiting, 2 completed, 2 not yet recruiting, 1 active not recruiting. 6 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 2, Recruiting 2, Completed 1, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Immunochemotherapy: new trials by email Literature Review of Immunochemotherapy trials Research Report on Immunochemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer Chemo only, Immunochemotherapy - Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma | Active not recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 300 | 2026-01-01 | 2026-09-22 | |
| Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC Cytoreductive surgery, Immunochemotherapy - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Jianxing He | 118 | 2025-09-10 | 2025-09-16 |
| Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC Immunochemotherapy combined with antiangiogenic, Immunochemotherapy - Non-Small Cell Lung Cancer, Anti Angiogenesis | Phase 2 | Not yet recruiting | Tang-Du Hospital | 178 | 2024-06-30 | 2024-06-26 |
| Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma Immunochemotherapy - Extranodal NK/T-cell Lymphoma | Phase 2 | Recruiting | Peking Union Medical College Hospital | 49 | 2024-05-20 | 2025-02-13 |
| Neoadjuvant SBRT in Localized Advanced HNSCC SBRT+immunochemotherpy, Immunochemotherapy, cetuximab+immunochemotharpy - Head and Neck Squamous Carcinoma | Phase 2 | Recruiting | Jiang Feng | 81 | 2023-10-01 | 2024-03-12 |
| Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV Immunochemotherapy - Lymphoma | Recruiting | Samsung Medical Center | 2000 | 2022-06-01 | 2026-10-13 | |
| Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma Immunochemotherapy - Central Nervous System Lymphoma | Phase 2 | Completed | University of Aarhus | 66 | 2007-05-01 | 2022-08-04 |
| An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Chemotherapy, Immunochemotherapy, Pegfilgrastim - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Hoffmann-La Roche | 53 | 2006-06-01 | 2016-11-21 |
| Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma Immunochemotherapy, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT - Mantle-Cell Lymphoma | Phase 2 | Unknown | Heidelberg University | 20 | 2004-07-01 | 2009-07-27 |
Carcinoma, Non-Small-Cell Lung (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Mantle-Cell (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Heidelberg University (1) · Hoffmann-La Roche (1) · Jiang Feng (1) · Jianxing He (1) · Peking Union Medical College Hospital (1) · Samsung Medical Center (1) · Tang-Du Hospital (1) · University of Aarhus (1)
China (4) · Colombia (1) · Denmark (1) · Germany (1) · Mexico (1) · South Korea (1)
Anthony D. Ho, Ph.D., Prof. (1) · Linna Liu (1)